Cite
HARVARD Citation
McGauran, N. et al. (n.d.). Early benefit assessment of new drugs in Germany: Framework for submission of dossiers by pharmaceutical companies. Medical writing. pp. 180-185. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
McGauran, N. et al. (n.d.). Early benefit assessment of new drugs in Germany: Framework for submission of dossiers by pharmaceutical companies. Medical writing. pp. 180-185. [Online].